Cite
HARVARD Citation
Anguita Sanchez, M. et al. (n.d.). Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding. European heart journal. p. . [Online].